Discontinuation of Zytiga®

HPS Pharmacies wish to give notice that Janssen-Cilag will be discontinuing all presentations of Zytiga^® as follows:

Zytiga^® Tablets
Abiraterone acetate 250 mg
ARTG 180314

Zytiga^® Tablets
Abiraterone acetate 500 mg
ARTG 275372

The discontinuation is expected to occur in May 2027. Alternative brands of abiraterone acetate remain available.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Download PDF